Alcohol biomarker screening in medical and surgical settings

Peter M. Miller, Claudia Spies, Tim Neumann, Martin A. Javors, A. M. Hoyumpa, John Roache, Amy Webb, Maryam Kashi, Francis E. Sharkey, Raymond F. Anton, Brent M. Egan, Jan Basile, Shaun Nguyen, Michael F. Fleming, Kathryn Sullivan Dillie

Producción científica: Articlerevisión exhaustiva

24 Citas (Scopus)


This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.

Idioma originalEnglish (US)
Páginas (desde-hasta)185-193
Número de páginas9
PublicaciónAlcoholism: Clinical and Experimental Research
EstadoPublished - feb 2006

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Medicine (miscellaneous)
  • Toxicology


Profundice en los temas de investigación de 'Alcohol biomarker screening in medical and surgical settings'. En conjunto forman una huella única.

Citar esto